NCT01844739View on ClinicalTrials.gov

A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Acne Vulgaris
Interventions
DRUG

NVN1000 4% Gel

Applied topically twice daily

DRUG

Vehicle Gel

Applied topically twice daily

Trial Locations (1)

19008

KGL, Broomall

All Listed Sponsors
lead

Novan, Inc.

INDUSTRY

NCT01844739 - A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel | Biotech Hunter | Biotech Hunter